4.5 Review

Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management

Related references

Note: Only part of the references are listed.
Review Gastroenterology & Hepatology

Outcomes of Nonalcoholic Steatohepatitis After Liver Transplantation: An Updated Meta-Analysis and Systematic Review

Jie Ning Yong et al.

Summary: This study conducted a time-dependent survival analysis comparing the survival of liver transplant recipients with and without nonalcoholic steatohepatitis (NASH). The overall survival was comparable between NASH and non-NASH patients after liver transplantation. However, NASH patients with higher model for end-stage liver disease scores had worse overall survival.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

Severity of systemic inflammation is the main predictor of ACLF and bleeding in individuals with acutely decompensated cirrhosis

Alberto Zanetto et al.

Summary: This study found that acutely decompensated cirrhosis is associated with abnormal coagulation function and that the severity of inflammation is the most important predictor of acute-on-chronic liver failure and bleeding. A predictive model was proposed to accurately identify individuals at higher risk of acute-on-chronic liver failure in acutely decompensated cirrhosis.

JOURNAL OF HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

Prevalence trends of non-alcoholic fatty liver disease among young men in Korea: A Korean military population-based cross-sectional study

Jaejun Lee et al.

Summary: This study investigated the prevalence of non-alcoholic fatty liver disease (NAFLD) in Korean men in their early 20s. The results showed an increasing trend in NAFLD prevalence and other metabolic dysfunctions from 2015 to 2021.

CLINICAL AND MOLECULAR HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Results of a multidisciplinary strategy to improve the management of cardiovascular risk factors after liver transplantation

Lydia Sastre et al.

Summary: The management of cardiovascular risk in liver transplantation recipients needs improvement. A multidisciplinary protocol was developed to standardize the identification and management of cardiovascular risk factors in the first year after transplantation, resulting in improved assessment and control of these factors.

LIVER TRANSPLANTATION (2022)

Review Medicine, General & Internal

Predictors of patient survival following liver transplant in non-alcoholic steatohepatitis: A systematic review and meta-analysis

Adam Minich et al.

Summary: This study conducted a systematic review and meta-analysis to identify clinical variables that predict post-liver transplantation survival in non-alcoholic steatohepatitis (NASH) patients. The findings provide valuable insights for optimizing patient outcomes and decision-making in the limited-resource liver transplantation setting.

ECLINICALMEDICINE (2022)

Review Gastroenterology & Hepatology

The burden of non-alcoholic steatohepatitis: A systematic review of health-related quality of life and patient-reported outcomes

Zobair Younossi et al.

Summary: NASH significantly impacts patients' HRQoL, especially in terms of physical functioning and fatigue. Symptoms such as fatigue, abdominal pain, anxiety/depression, cognition problems, and poor sleep quality can affect patients' ability to work, perform daily activities, and the quality of relationships.

JHEP REPORTS (2022)

Article Surgery

Effect of QT interval prolongation on cardiac arrest following liver transplantation and derivation of a risk index

Anoop N. Koshy et al.

Summary: In patients undergoing liver transplantation, a pretransplant QTc >= 480 milliseconds is associated with a 5-fold increased risk of periprocedural cardiac arrest and ventricular arrhythmias. The Cardiac Arrest Risk Index (CARI) score, including factors like QTc duration, MELD score, age, and gender, shows moderate discrimination in predicting these events. Further research is needed to determine if heightened perioperative cardiac surveillance and other interventions can help mitigate the risk.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

Article Gastroenterology & Hepatology

Impact of everolimus on survival after liver transplanta-tion for hepatocellular carcinoma

Incheon Kang et al.

Summary: EVR in combination with CNIs may prolong long-term survival in patients undergoing LT for HCC, with the EVR group showing more aggressive tumor biology characteristics such as a higher number of tumors.

CLINICAL AND MOLECULAR HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease

Seong Hee Kang et al.

CLINICAL AND MOLECULAR HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

CAD-LT score effectively predicts risk of significant coronary artery disease in liver transplant candidates

Rayan Jo Rachwan et al.

Summary: The study effectively stratified LT candidates based on their risk of significant coronary artery disease using the CAD-LT score and algorithm, guiding a more targeted cardiac evaluation prior to liver transplantation.

JOURNAL OF HEPATOLOGY (2021)

Article Surgery

Disease-specific waitlist outcomes in liver transplantation - a retrospective study

Shunji Nagai et al.

Summary: This study aimed to evaluate discrepancies in waitlist outcomes among different liver diseases, finding that NASH and PBC had higher risk of mortality compared to ALD with similar MELD-Na scores, while positive prognostic impact of transplantation was not seen until higher scores in ALD.

TRANSPLANT INTERNATIONAL (2021)

Review Gastroenterology & Hepatology

Evaluation and management of extrahepatic manifestations of nonalcoholic fatty liver disease

Karn Wijarnpreecha et al.

Summary: Nonalcoholic fatty liver disease (NAFLD) is a multisystemic disease and a rapidly growing cause of chronic liver disease in children and adults worldwide. Diagnosis and management of extrahepatic manifestations of NAFLD, including cardiovascular disease (CVD), type 2 diabetes mellitus, metabolic syndrome, chronic kidney disease, obstructive sleep apnea, polycystic ovarian syndrome, hypothyroidism, psoriasis, and extrahepatic malignancy are crucial for the treatment of patients with NAFLD.

CLINICAL AND MOLECULAR HEPATOLOGY (2021)

Article Biochemistry & Molecular Biology

Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial

V. Ratziu et al.

Summary: Aramchol showed potential improvements in liver steatosis and fibrosis in NASH patients, but did not significantly reduce hepatic triglycerides. However, it demonstrated positive effects on liver histology and ALT levels in the clinical trial.

NATURE MEDICINE (2021)

Article Cardiac & Cardiovascular Systems

GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTs

Dario Giugliano et al.

Summary: Glucagon-like peptide-1 receptor agonists have significant benefits on cardiovascular and renal outcomes in patients with type 2 diabetes, including reducing major cardiovascular events, hospitalization for heart failure, all-cause mortality, and the incidence of macroalbuminuria.

CARDIOVASCULAR DIABETOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Coronary artery calcium on standard chest computed tomography predicts cardiovascular events after liver transplantation

Alessandro Zorzi et al.

Summary: The study showed that the CAC score calculated on a standard chest CT can effectively predict the risk of cardiac events after liver transplantation, providing guidance for preoperative risk stratification.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2021)

Article Gastroenterology & Hepatology

Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States

Donghee Kim et al.

Summary: This study demonstrated that metabolic dysfunction-associated fatty liver disease (MAFLD) was associated with an increased risk of all-cause mortality in US adults, while non-alcoholic fatty liver disease (NAFLD) showed no association with all-cause mortality after adjusting for metabolic risk factors. Individuals who met the criteria for MAFLD but not NAFLD had a higher risk of all-cause mortality.

JOURNAL OF HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

PPAR-γ-induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASH

Amalia Gastaldelli et al.

Summary: The study found that PPAR-gamma agonists, along with an increase in ADPN levels, a decrease in VF, and an improvement in VF/SC fat distribution, are closely related to improving the pathological condition of patients with NASH.

LIVER INTERNATIONAL (2021)

Review Gastroenterology & Hepatology

Metabolic Complications in Liver Transplantation Recipients: How We Can Optimize Long-Term Survival

Amirhossein Azhie et al.

Summary: Liver transplantation recipients have seen significant improvements in short-term survival due to advances in surgical techniques and immunosuppressive regimens, but long-term survival is affected by metabolic disorders such as diabetes and dyslipidemia. Pretransplant metabolic impairments, weight gain, and physical inactivity can worsen the situation, while the long-term use of immunosuppressants may also contribute to metabolic issues. More clinical trials are needed to better understand and manage metabolic complications in this high-risk population.

LIVER TRANSPLANTATION (2021)

Article Gastroenterology & Hepatology

Redefining Cirrhotic Cardiomyopathy for the Modern Era

Manhal Izzy et al.

HEPATOLOGY (2020)

Review Gastroenterology & Hepatology

Nonalcoholic Steatohepatitis After Liver Transplantation

Thomas G. Cotter et al.

LIVER TRANSPLANTATION (2020)

Article Surgery

OPTN/SRTR 2018 Annual Data Report: Liver

A. Kwong et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2020)

Editorial Material Gastroenterology & Hepatology

Redefining non-alcoholic fatty liver disease: what's in a name?

[Anonymous]

LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)

Review Gastroenterology & Hepatology

Endoscopic bariatric and metabolic therapies for non-alcoholic fatty liver disease: Evidence and perspectives

Federico Salomone et al.

LIVER INTERNATIONAL (2020)

Review Gastroenterology & Hepatology

NAFLD and liver transplantation: Disease burden, current management and future challenges

Patrizia Burra et al.

JHEP REPORTS (2020)

Article Gastroenterology & Hepatology

Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates

Zobair Younossi et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)

Article Gastroenterology & Hepatology

Differing Impact of Sarcopenia and Frailty in Nonalcoholic Steatohepatitis and Alcoholic Liver Disease

Rahima A. Bhanji et al.

LIVER TRANSPLANTATION (2019)

Article Pharmacology & Pharmacy

Emerging Role of SGLT-2 Inhibitors for the Treatment of Obesity

Maria J. Pereira et al.

DRUGS (2019)

Article Gastroenterology & Hepatology

Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study

Debashis Haldar et al.

JOURNAL OF HEPATOLOGY (2019)

Article Gastroenterology & Hepatology

The Impact of Coronary Artery Disease and Statins on Survival After Liver Transplantation

Samarth S. Patel et al.

LIVER TRANSPLANTATION (2019)

Review Gastroenterology & Hepatology

Sarcopenia in Chronic Liver Disease: Impact on Outcomes

Poh Hwa Ooi et al.

LIVER TRANSPLANTATION (2019)

Article Gastroenterology & Hepatology

The evolution and impact of sarcopenia pre- and post-liver transplantation

Rahima A. Bhanji et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)

Article Surgery

Sleeve Gastrectomy After Liver Transplantation: Feasibility and Outcomes

Michael Osseis et al.

OBESITY SURGERY (2018)

Article Gastroenterology & Hepatology

Liver transplantation for NASH cirrhosis is not performed at the expense of major post-operative morbidity

Eline H. van den Berg et al.

DIGESTIVE AND LIVER DISEASE (2018)

Article Gastroenterology & Hepatology

Long-term outcomes of patients undergoing simultaneous liver transplantation and sleeve gastrectomy

Daniel Zamora-Valdes et al.

HEPATOLOGY (2018)

Review Gastroenterology & Hepatology

Sarcopenic obesity in cirrhosisThe confluence of 2 prognostic titans

Tannaz Eslamparast et al.

LIVER INTERNATIONAL (2018)

Article Gastroenterology & Hepatology

Coronary artery disease in decompensated patients undergoing liver transplantation evaluation

Samarth S. Patel et al.

LIVER TRANSPLANTATION (2018)

Review Cell Biology

mTOR Inhibitor Therapy and Metabolic Consequences: Where Do We Stand?

Aleksandra Kezic et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)

Review Endocrinology & Metabolism

Post-Liver Transplantation Diabetes Mellitus: A Review of Relevance and Approach to Treatment

Maria J. Pelaez-Jaramillo et al.

DIABETES THERAPY (2018)

Review Endocrinology & Metabolism

Post-Liver Transplantation Diabetes Mellitus: A Review of Relevance and Approach to Treatment

Maria J. Pelaez-Jaramillo et al.

DIABETES THERAPY (2018)

Article Gastroenterology & Hepatology

Liver transplantation in patients with multiple organ failures: Feasibility and outcomes

Paul J. Thuluvath et al.

JOURNAL OF HEPATOLOGY (2018)

Review Gastroenterology & Hepatology

Liver Transplantation and Bariatric Surgery: Timing and Outcomes

Tayyab S. Diwan et al.

LIVER TRANSPLANTATION (2018)

Article Gastroenterology & Hepatology

Cardiovascular morbidity and mortality after liver transplantation: The protective role of mycophenolate mofetil

Delia D'Avola et al.

LIVER TRANSPLANTATION (2017)

Article Endocrinology & Metabolism

Outcomes in patients with diabetes 10 years after liver transplantation

Agustin Ramos-Prol et al.

JOURNAL OF DIABETES (2017)

Review Gastroenterology & Hepatology

The story of HCC in NAFLD: from epidemiology, across pathogenesis, to prevention and treatment

Cristina Margini et al.

LIVER INTERNATIONAL (2016)

Article Gastroenterology & Hepatology

The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe

Zobair M. Younossi et al.

HEPATOLOGY (2016)

Article Medicine, General & Internal

Sarcopenia and Sarcopenic Obesity Are Prognostic Factors for Overall Survival in Patients with Cirrhosis

Nagisa Hara et al.

INTERNAL MEDICINE (2016)

Article Gastroenterology & Hepatology

Nonalcoholic steatohepatitis is strongly associated with sarcopenic obesity in patients with cirrhosis undergoing liver transplant evaluation

Sandra Carias et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines: Liver transplantation

Patrizia Burra et al.

JOURNAL OF HEPATOLOGY (2016)

Article Gastroenterology & Hepatology

Cardiovascular disease after liver transplantation: When, What, and Who Is at Risk

Lynn A. Fussner et al.

LIVER TRANSPLANTATION (2015)

Article Gastroenterology & Hepatology

Post-liver transplantation sarcopenia in cirrhosis: A prospective evaluation

Cynthia Tsien et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)

Review Endocrinology & Metabolism

Obesity-associated mechanisms of hepatocarcinogenesis

Raffi Karagozian et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2014)

Review Gastroenterology & Hepatology

Posttransplant Sarcopenia: An Underrecognized Early Consequence of Liver Transplantation

Srinivasan Dasarathy

DIGESTIVE DISEASES AND SCIENCES (2013)

Article Surgery

Safety and feasibility of sleeve gastrectomy in morbidly obese patients following liver transplantation

Matthew Y. C. Lin et al.

SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2013)

Article Surgery

Long-term outcome of 'long-term liver transplant survivors'

Angel Rubin et al.

TRANSPLANT INTERNATIONAL (2013)

Article Gastroenterology & Hepatology

Independent Association Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease in the US Population

Maria Stepanova et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)

Article Medicine, General & Internal

Diagnostic Accuracy of Fractional Flow Reserve From Anatomic CT Angiography

James K. Min et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)

Article Gastroenterology & Hepatology

Major influence of renal function on hyperlipidemia after living donor liver transplantation

Qi Ling et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2012)

Article Gastroenterology & Hepatology

Characteristics of Patients With Nonalcoholic Steatohepatitis Who Develop Hepatocellular Carcinoma

Kohichiroh Yasui et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)

Article Gastroenterology & Hepatology

Safety and Effectiveness of Ezetimibe in Liver Transplant Recipients with Hypercholesterolemia

Fawaz Almutairi et al.

LIVER TRANSPLANTATION (2009)

Review Medicine, General & Internal

Assessing risk of myocardial infarction and stroke: new data from the Prospective Cardiovascular Munster (PROCAM) study

G. Assmann et al.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2007)